MyGrace - weil GESUNDHEIT zählt

MyGrace - weil GESUNDHEIT zählt

MyGrace - weil GESUNDHEIT zählt

Referenzen - nach Nummern geordnet

Suchen Sie eine bestimmte Publikation, benutzen Sie die Suchfunktion der Webseite (Chrome: Ctrl + F)

  1. Geleijnse, Johanna M., Cees Vermeer, Diederick E. Grobbee, Leon J. Schurgers, Marjo H. J. Knapen, Irene M. van der Meer, Albert Hofman, und Jacqueline C. M. Witteman. „Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study“. The Journal of Nutrition 134, Nr. 11 (1. November 2004): 3100–3105. https://doi.org/10.1093/jn/134.11.3100.
  2. Wei, Fang-Fei, Nadja E. A. Drummen, Lutgarde Thijs, Lotte Jacobs, Marjolein Herfs, Cynthia van’’t Hoofd, Cees Vermeer, und Jan A. Staessen. „Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys“. Pulse 4, Nr. 2–3 (2016): 85–91. https://doi.org/10.1159/000448008.
  3. Puzantian, Houry, Scott R. Akers, Garrett Oldland, Khuzaima Javaid, Rachana Miller, Yueya Ge, Bilal Ansari, u. a. „Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness“. American Journal of Hypertension 31, Nr. 9 (3. August 2018): 988–94. https://doi.org/10.1093/ajh/hpy079.
  4. Mansour, Anthony G., Essa Hariri, Yazan Daaboul, Serge Korjian, Andrew El Alam, Athanase D. Protogerou, Hala Kilany, Albert Karam, Antoine Stephan, und Sola Aoun Bahous. „Vitamin K2 supplementation and arterial stiffness among renal transplant recipients—a single-arm, single-center clinical trial“. Journal of the American Society of Hypertension 11, Nr. 9 (September 2017): 589–97. https://doi.org/10.1016/j.jash.2017.07.001.
  5. Roumeliotis, Stefanos, Evangelia Dounousi, Theodoros Eleftheriadis, und Vassilios Liakopoulos. „Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.“ International journal of molecular sciences 20, Nr. 3 (1. Februar 2019). https://doi.org/10.3390/ijms20030628.
  6. Mayer, Otto, Jitka Seidlerová, Jan Bruthans, Jan Filipovský, Katarina Timoracká, Jiří Vaněk, Lenka Cerná, u. a. „Desphospho-Uncarboxylated Matrix Gla-Protein Is Associated with Mortality Risk in Patients with Chronic Stable Vascular Disease“. Atherosclerosis 235, Nr. 1 (Juli 2014): 162–68. https://doi.org/10.1016/j.atherosclerosis.2014.04.027.
  7. Xu, Qingdong, Huankai Guo, Shirong Cao, Qian Zhou, Jiexin Chen, Ming Su, Siying Chen, Songqin Jiang, Xiaofeng Shi, und Yueqiang Wen. „Associations of Vitamin K Status with Mortality and Cardiovascular Events in Peritoneal Dialysis Patients“. International Urology and Nephrology 51, Nr. 3 (März 2019): 527–34. https://doi.org/10.1007/s11255-019-02080-x.
  8. Schurgers, Leon J., Ellen C.M. Cranenburg, und Cees Vermeer. „Matrix Gla-protein: The calcification inhibitor in need of vitamin K“. Thrombosis and Haemostasis 100, Nr. 4 (22. November 2008): 593–603. https://doi.org/10.1160/TH08-02-0087.
  9. Boström, K, K E Watson, S Horn, C Wortham, I M Herman, und L L Demer. „Bone morphogenetic protein expression in human atherosclerotic lesions.“ Journal of Clinical Investigation 91, Nr. 4 (April 1993): 1800–1809. https://doi.org/10.1172/JCI116391.
  10. Schurgers, Leon J., Henri M. H. Spronk, Berry A. M. Soute, Paul M. Schiffers, Jo G. R. DeMey, und Cees Vermeer. „Regression of Warfarin-Induced Medial Elastocalcinosis by High Intake of Vitamin K in Rats“. Blood 109, Nr. 7 (1. April 2007): 2823–31. https://doi.org/10.1182/blood-2006-07-035345.
  11. Shaw, Leslee J., Paolo Raggi, Daniel S. Berman, und Tracy Q. Callister. „Coronary Artery Calcium as a Measure of Biologic Age“. Atherosclerosis 188, Nr. 1 (1. September 2006): 112–19. https://doi.org/10.1016/j.atherosclerosis.2005.10.010.
  12. Taylor, Allen J., Jody Bindeman, Irwin Feuerstein, Felix Cao, Michael Brazaitis, und Patrick G. O’Malley. „Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project“. Journal of the American College of Cardiology 46, Nr. 5 (6. September 2005): 807–14. https://doi.org/10.1016/j.jacc.2005.05.049.
  13. Brandenburg Vincent M., Reinartz Sebastian, Kaesler Nadine, Krüger Thilo, Dirrichs Tim, Kramann Rafael, Peeters Frederique, u. a. „Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation“. Circulation 135, Nr. 21 (23. Mai 2017): 2081–83. https://doi.org/10.1161/CIRCULATIONAHA.116.027011.
  14. Delanaye, Pierre, Jean Marie Krzesinski, Xavier Warling, Martial Moonen, Nicole Smelten, Laurent Médart, Hans Pottel, und Etienne Cavalier. „Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients“. BMC Nephrology 15, Nr. 1 (4. Dezember 2014): 145. https://doi.org/10.1186/1471-2369-15-145.
  15. Peeters, Frederique E. C. M., Steven J. R. Meex, Marc R. Dweck, Elena Aikawa, Harry J. G. M. Crijns, Leon J. Schurgers, und Bas L. J. H. Kietselaer. „Calcific Aortic Valve Stenosis: Hard Disease in the Heart A Biomolecular Approach towards Diagnosis and Treatment“. European Heart Journal 39, Nr. 28 (21. Juli 2018): 2618–24. https://doi.org/10.1093/eurheartj/ehx653.
  16. Michaux, Arnaud, Benjamin Matagrin, Jean-Valéry Debaux, Leon J. Schurgers, Etienne Benoit, und Virginie Lattard. „Missense Mutation of VKORC1 Leads to Medial Arterial Calcification in Rats“. Scientific Reports 8, Nr. 1 (13. September 2018): 13733. https://doi.org/10.1038/s41598-018-31788-6.
  17. Nollet, Lukas, Matthias Van Gils, Shana Verschuere, und Olivier Vanakker. „The Role of Vitamin K and Its Related Compounds in Mendelian and Acquired Ectopic Mineralization Disorders“. International Journal of Molecular Sciences 20, Nr. 9 (30. April 2019). https://doi.org/10.3390/ijms20092142.
  18. Schurgers, Leon J. „Role of Vitamin K in Arterial Calcifications and Cardiovascular Diseases – Präsentation“, 2017, 17.
    Download: https://mygrace.ch/wp-content/uploads/2022/05/Schurgers-Role-of-Vitamin-K-in-arterial-calcifications-and-c.pdf
  19. Wei, Fang-Fei, Lutgarde Thijs, Zhen-Yu Zhang, Lotte Jacobs, Wen-Yi Yang, Erika Salvi, Lorena Citterio, u. a. „The Risk of Nephrolithiasis Is Causally Related to Inactive Matrix Gla Protein, a Marker of Vitamin K Status: A Mendelian Randomization Study in a Flemish Population“. Nephrology Dialysis Transplantation 33, Nr. 3 (1. März 2018): 514–22. https://doi.org/10.1093/ndt/gfx014.
  20. Bolland, Mark J, Andrew Grey, Alison Avenell, Greg D Gamble, und Ian R Reid. „Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis“. The BMJ 342 (19. April 2011). https://doi.org/10.1136/bmj.d2040.
  21. Murshed, Monzur, Thorsten Schinke, Marc D McKee, und Gerard Karsenty. „Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins.“ The Journal of cell biology 165, Nr. 5 (7. Juni 2004): 625–30. https://doi.org/10.1083/jcb.200402046.
  22. Pucaj, Kresimir, Henrik Rasmussen, Mona Møller, und Tom Preston. „Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7“. Toxicology Mechanisms and Methods 21, Nr. 7 (1. September 2011): 520–32. https://doi.org/10.3109/15376516.2011.568983.
  23. Mona, Møller, Gjelstad Ingrid M. Fange, Baksaas Ingebjørg, Grande Tone, Aukrust Inger Reidun, und Drevon Christian A. „Bioavailability and Chemical/Functional Aspects of Synthetic MK-7 vs Fermentation-Derived MK-7 in Randomised Controlled Trials“. International Journal for Vitamin and Nutrition Research 87, Nr. 5–6 (4. Juli 2016): 1–15. https://doi.org/10.1024/0300-9831/a000258.
  24. Simes, Dina C., Carla S. B. Viegas, Nuna Araújo, und Catarina Marreiros. „Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies“. International Journal of Molecular Sciences 20, Nr. 17 (Januar 2019): 4150. https://doi.org/10.3390/ijms20174150.
  25. Jaques, David A., Edward Pivin, Menno Pruijm, Daniel Ackermann, Idris Guessous, Georg Ehret, Fang-Fei Wei, u. a. „Renal Resistive Index Is Associated With Inactive Matrix Gla (Γ‐Carboxyglutamate) Protein in an Adult Population‐Based Study (RRI)“. Journal of the American Heart Association, 17. September 2019. https://doi.org/10.1161/jaha.119.013558.
  26. Magaziner, Jay, William Hawkes, J. Richard Hebel, Sheryl Itkin Zimmerman, Kathleen M. Fox, Melissa Dolan, Gerald Felsenthal, und John Kenzora. „Recovery From Hip Fracture in Eight Areas of Function“. The Journals of Gerontology: Series A 55, Nr. 9 (1. September 2000): M498–507. https://doi.org/10.1093/gerona/55.9.M498.
  27. Park-Wyllie, Laura Y., Muhammad M. Mamdani, David N. Juurlink, Gillian A. Hawker, Nadia Gunraj, Peter C. Austin, Daniel B. Whelan, Peter J. Weiler, und Andreas Laupacis. „Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women“. JAMA 305, Nr. 8 (23. Februar 2011): 783–89. https://doi.org/10.1001/jama.2011.190.
  28. Sato, Toshiro, Leon J Schurgers, und Kazuhiro Uenishi. „Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women“. Nutrition Journal 11 (12. November 2012): 93. https://doi.org/10.1186/1475-2891-11-93.
  29. Vermeer, Cees, Joyce Raes, Cynthia van ’t Hoofd, Marjo H. J. Knapen, und Sofia Xanthoulea. „Menaquinone Content of Cheese“. Nutrients 10, Nr. 4 (4. April 2018). https://doi.org/10.3390/nu10040446.
  30. Gröber, U, J Reichrath, MF Holick, und K Kisters. „Vitamin K: an old vitamin in a new perspective“. Dermato-endocrinology 6, Nr. 1 (21. Januar 2015). https://doi.org/10.4161/19381972.2014.968490.
  31. Summeren, Marieke J. H. van, Lavienja A. J. L. M. Braam, Marc R. Lilien, Leon J. Schurgers, Wietse Kuis, und Cees Vermeer. „The Effect of Menaquinone-7 (Vitamin K2) Supplementation on Osteocalcin Carboxylation in Healthy Prepubertal Children“. British Journal of Nutrition 102, Nr. 8 (Oktober 2009): 1171–78. https://doi.org/10.1017/S0007114509382100.
  32. Caluwé, Rogier, Stefaan Vandecasteele, Bruno Van Vlem, Cees Vermeer, und An S. De Vriese. „Vitamin K2 Supplementation in Haemodialysis Patients: A Randomized Dose-Finding Study“. Nephrology Dialysis Transplantation 29, Nr. 7 (1. Juli 2014): 1385–90. https://doi.org/10.1093/ndt/gft464.
  33. Wei, Fang-Fei, Sander Trenson, Lutgarde Thijs, Qi-Fang Huang, Zhen-Yu Zhang, Wen-Yi Yang, Paula Moliterno, u. a. „Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population“. Nephrology Dialysis Transplantation 33, Nr. 7 (Juli 2018): 1122–28. https://doi.org/10.1093/ndt/gfx258.
  34. Li, Yan, Jie peng Chen, Lili Duan, und Shuzhuang Li. „Effect of Vitamin K2 on Type 2 Diabetes Mellitus: A Review“. Diabetes Research and Clinical Practice 136 (1. Februar 2018): 39–51. https://doi.org/10.1016/j.diabres.2017.11.020.
  35. Lee, Na Kyung, Hideaki Sowa, Eiichi Hinoi, Mathieu Ferron, Jong Deok Ahn, Cyrille Confavreux, Romain Dacquin, u. a. „Endocrine regulation of energy metabolism by the skeleton“. Cell 130, Nr. 3 (10. August 2007): 456–69. https://doi.org/10.1016/j.cell.2007.05.047.
  36. Debaux, Jean Valéry, Abdessalem Hammed, Brigitte Barbier, Thomas Chetot, Etienne Benoit, Sébastien Lefebvre, und Virginie Lattard. „Establishment of the Variation of Vitamin K Status According to VKORC1 Point Mutations Using Rat Models“. Nutrients 11, Nr. 9 (3. September 2019). https://doi.org/10.3390/nu11092076.
  37. Iki, M., J. Tamaki, Y. Fujita, K. Kouda, A. Yura, E. Kadowaki, Y. Sato, u. a. „Serum Undercarboxylated Osteocalcin Levels Are Inversely Associated with Glycemic Status and Insulin Resistance in an Elderly Japanese Male Population: Fujiwara-Kyo Osteoporosis Risk in Men (FORMEN) Study“. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 23, Nr. 2 (Februar 2012): 761–70. https://doi.org/10.1007/s00198-011-1600-7.
  38. Beaudin, Sarah, Leila Kokabee, und JoEllen Welsh. „Divergent Effects of Vitamins K1 and K2 on Triple Negative Breast Cancer Cells“. Oncotarget 10, Nr. 23 (19. März 2019): 2292–2305. https://doi.org/10.18632/oncotarget.26765.
  39. Nimptsch, Katharina, Sabine Rohrmann, Rudolf Kaaks, und Jakob Linseisen. „Dietary Vitamin K Intake in Relation to Cancer Incidence and Mortality: Results from the Heidelberg Cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)“. The American Journal of Clinical Nutrition 91, Nr. 5 (1. Mai 2010): 1348–58. https://doi.org/10.3945/ajcn.2009.28691.
  40. Lamson, Davis W., und Steven M. Plaza. „The Anticancer Effects of Vitamin K“. Alternative Medicine Review: A Journal of Clinical Therapeutic 8, Nr. 3 (August 2003): 303–18. https://altmedrev.com/wp-content/uploads/2019/02/v8-3-303.pdf.
  1. Yaguchi, M., K. Miyazawa, T. Katagiri, J. Nishimaki, M. Kizaki, K. Tohyama, und K. Toyama. „Vitamin K2 and Its Derivatives Induce Apoptosis in Leukemia Cells and Enhance the Effect of All- Trans Retinoic Acid“. Leukemia 11, Nr. 6 (Juni 1997): 779–87. https://doi.org/10.1038/sj.leu.2400667.
  2. Iguchi, Tomotaka, Keisuke Miyazawa, Minoru Asada, Akihiko Gotoh, Shuki Mizutani, und Kazuma Ohyashiki. „Combined treatment of leukemia cells with vitamin K2 and 1α,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1“. International Journal of Oncology 27, Nr. 4 (1. Oktober 2005): 893–900. https://doi.org/10.3892/ijo.27.4.893.
  3. Yoshida, Tsuyoshi, Keisuke Miyazawa, Ikuma Kasuga, Tomohisa Yokoyama, Kazushige Minemura, Kenta Ustumi, Masahiro Aoshima, und Kazuma Ohyashiki. „Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer“. International Journal of Oncology 23, Nr. 3 (1. September 2003): 627–32. https://doi.org/10.3892/ijo.23.3.627.
  4. „Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages – Sada – 2010 – European Journal of Haematology – Wiley Online Library“. Zugegriffen 9. November 2019. https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0609.2010.01530.x
  5. Yokoyama, Tomohisa, Keisuke Miyazawa, Munekazu Naito, Juri Toyotake, Testuzo Tauchi, Masahiro Itoh, Akira Yuo, u. a. „Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells“. Autophagy 4, Nr. 5 (1. Juli 2008): 629–40. https://doi.org/10.4161/auto.5941.
  6. Okamoto, Hiroshi. „+Vitamin K and Rheumatoid Arthritis“. IUBMB Life 60, Nr. 6 (2008): 355–61. https://doi.org/10.1002/iub.41.
  7. Booth, Sarah L. „Skeletal Functions of Vitamin K-Dependent Proteins: Not Just for Clotting Anymore“. Nutrition Reviews 55, Nr. 7 (1. Juli 1997): 282–84. https://doi.org/10.1111/j.1753-4887.1997.tb01619.x.
  8. Borchmann, Sven, Melita Cirillo, Helen Goergen, Lydia Meder, Stephanie Sasse, Stefanie Kreissl, Paul Jan Bröckelmann, u. a. „Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma“. Journal of Clinical Oncology, 17. Oktober 2019. https://doi.org/10.1200/JCO.19.00985.
  9. Kiely, Maeve, Spencer J. Hodgins, B. Anne Merrigan, Shona Tormey, Patrick A. Kiely, und Eibhlís M. O’Connor. „Real-Time Cell Analysis of the Inhibitory Effect of Vitamin K2 on Adhesion and Proliferation of Breast Cancer Cells“. Nutrition Research 35, Nr. 8 (1. August 2015): 736–43. https://doi.org/10.1016/j.nutres.2015.05.014.
  10. Cranenburg, Ellen C. M., Leon J. Schurgers, und Cees Vermeer. „Vitamin K: The Coagulation Vitamin That Became Omnipotent“. Thrombosis and Haemostasis 98, Nr. 1 (Juli 2007): 120–25. https://www.ncbi.nlm.nih.gov/pubmed/17598002.
  11. Cozzolino, Mario, Michela Mangano, Andrea Galassi, Paola Ciceri, Piergiorgio Messa, und Sagar Nigwekar. „Vitamin K in Chronic Kidney Disease“. Nutrients 11, Nr. 1 (14. Januar 2019). https://doi.org/10.3390/nu11010168.
  12. Viegas, Carla, Nuna Araújo, Catarina Marreiros, und Dina Simes. „The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts“. Aging (Albany NY) 11, Nr. 12 (26. Juni 2019): 4274–99. https://doi.org/10.18632/aging.102046.
  13. Aoun, Mabel, Maha Makki, Hiba Azar, Hiam Matta, und Dania Nehme Chelala. „High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial“. BMC Nephrology, 2017. https://doi.org/10.1186/s12882-017-0609-3.
  14. Neradova, A., S. P. Schumacher, I. Hubeek, P. Lux, L. J. Schurgers, und M. G. Vervloet. „Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study“. BMC Nephrology 18 (2. Mai 2017). https://doi.org/10.1186/s12882-017-0560-3.
  15. Viegas, Carla S. B., Lúcia Santos, Anjos L. Macedo, António A. Matos, Ana P. Silva, Pedro L. Neves, An Staes, u. a. „Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein)“. Arteriosclerosis, Thrombosis, and Vascular Biology 38, Nr. 3 (2018): 575–87. https://doi.org/10.1161/ATVBAHA.117.310578.
  16. Silva, Ana Paula, Carla Viegas, Dina Simes, Filipa Mendes, Nelson Tavares, Fatima Rato, Nelio Santos, und Pedro Neves. „GLA-RICH PROTEIN AS A NOVEL MARKER FOR CALCIFICATIONS IN DIABETIC PATIENTS WITH CKD“. Nephrology Dialysis Transplantation 33, Nr. suppl_1 (1. Mai 2018): i493–i493. https://doi.org/10.1093/ndt/gfy104.SP430.
  17. Li, Jianrong, Judith C. Lin, Hong Wang, James W. Peterson, Barbara C. Furie, Bruce Furie, Sara L. Booth, Joseph J. Volpe, und Paul A. Rosenberg. „Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons“. The Journal of Neuroscience 23, Nr. 13 (2. Juli 2003): 5816–26. https://doi.org/10.1523/JNEUROSCI.23-13-05816.2003.
  18. Li, Jianrong, Hong Wang, und Paul A. Rosenberg. „Vitamin K Prevents Oxidative Cell Death by Inhibiting Activation of 12-Lipoxygenase in Developing Oligodendrocytes“. Journal of neuroscience research 87, Nr. 9 (Juli 2009): 1997–2005. https://doi.org/10.1002/jnr.22029.
  19. Craft, Suzanne. „Insulin Resistance Syndrome and Alzheimer’s Disease: Age- and Obesity-Related Effects on Memory, Amyloid, and Inflammation“. Neurobiology of Aging 26 Suppl 1 (Dezember 2005): 65–69. https://doi.org/10.1016/j.neurobiolaging.2005.08.021.
  20. Allison, A. C. „The Possible Role of Vitamin K Deficiency in the Pathogenesis of Alzheimer’s Disease and in Augmenting Brain Damage Associated with Cardiovascular Disease“. Medical Hypotheses 57, Nr. 2 (August 2001): 151–55. https://doi.org/10.1054/mehy.2001.1307.
  21. Saputra, Wahyu Dwi, Nao Aoyama, Michio Komai, und Hitoshi Shirakawa. „Menaquinone-4 Suppresses Lipopolysaccharide-Induced Inflammation in MG6 Mouse Microglia-Derived Cells by Inhibiting the NF-ΚB Signaling Pathway“. International Journal of Molecular Sciences 20, Nr. 9 (Januar 2019): 2317. https://doi.org/10.3390/ijms20092317.
  22. Alisi, Ludovico, Roberta Cao, Cristina De Angelis, Arturo Cafolla, Francesca Caramia, Gaia Cartocci, Aloisa Librando, und Marco Fiorelli. „The Relationships Between Vitamin K and Cognition: A Review of Current Evidence“. Frontiers in Neurology 10 (19. März 2019). https://doi.org/10.3389/fneur.2019.00239.
  23. Abdel-Rahman, Mahran S., Eman A. M. Alkady, und Sameh Ahmed. „Menaquinone-7 as a Novel Pharmacological Therapy in the Treatment of Rheumatoid Arthritis: A Clinical Study“. European Journal of Pharmacology 761 (15. August 2015): 273–78. https://doi.org/10.1016/j.ejphar.2015.06.014.
  24. Rhéaume-Bleue, Kate. „Choosing the Right Vitamin K2: Menaquinone-4 vs Menaquinone-7“. Natural Medicine Journal. Zugegriffen 12. November 2019. https://www.naturalmedicinejournal.com/journal/2015-10/choosing-right-vitamin-k2-menaquinone-4-vs-menaquinone-7.
  25. „Vitamin K — its essential role in craniofacial development – Howe – 1994 – Australian Dental Journal – Wiley Online Library“. Zugegriffen 12. November 2019.  https://pubmed.ncbi.nlm.nih.gov/8018065/
  26. Merewood, Anne, Supriya D. Mehta, Tai C. Chen, Howard Bauchner, und Michael F. Holick. „Association between Vitamin D Deficiency and Primary Cesarean Section“. The Journal of Clinical Endocrinology and Metabolism 94, Nr. 3 (März 2009): 940–45. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681281/.
  27. Summeren, Marieke J. H. van, Silvia C. C. M. van Coeverden, Leon J. Schurgers, Lavienja A. J. L. M. Braam, Florence Noirt, Cuno S. P. M. Uiterwaal, Wietse Kuis, und Cees Vermeer. „Vitamin K Status Is Associated with Childhood Bone Mineral Content“. British Journal of Nutrition 100, Nr. 4 (Oktober 2008): 852–58. https://doi.org/10.1017/S0007114508921760.
  28. Hyppönen, Elina, Esa Läärä, Antti Reunanen, Marjo-Riitta Järvelin, und Suvi M Virtanen. „Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study“. The Lancet 358, Nr. 9292 (3. November 2001): 1500–1503. https://doi.org/10.1016/S0140-6736(01)06580-1.
  29. „The Scientific Approach of Weston Price“. The Weston A. Price Foundation. Zugegriffen 12. November 2019. https://www.westonaprice.org/health-topics/nutrition-greats/the-scientific-approach-of-weston-price/.
  30. „A filmed message from Dr Weston A Price“. Zugegriffen 12. November 2019. https://www.youtube.com/watch?v=qdtnSzUYZkU.
  31. Stafford, Darrel W., Harold R. Roberts, und Cees Vermeer. „Vitamin K Supplementation during Oral Anticoagulation: Cautions“. Blood 109, Nr. 8 (15. April 2007): 3607–3607. https://doi.org/10.1182/blood-2006-12-061200.
  32. Sconce, Elizabeth, Peter Avery, Hilary Wynne, und Farhad Kamali. „Vitamin K Supplementation Can Improve Stability of Anticoagulation for Patients with Unexplained Variability in Response to Warfarin“. Blood 109, Nr. 6 (15. März 2007): 2419–23. https://doi.org/10.1182/blood-2006-09-049262.
  33. Wahlqvist, Mark L., Kiyoshi Tanaka, und \dBing-Hsiean Tzeng. „Clinical Decision-Making for Vitamin K-1 and K-2 Deficiency and Coronary Artery Calcification with Warfarin Therapy: Are Diet, Factor Xa Inhibitors or Both the Answer?“ Asia Pacific Journal of Clinical Nutrition 22, Nr. 3 (August 2013): 492–96. http://apjcn.nhri.org.tw/server/APJCN/22/3/492.pdf.
  34. Theuwissen, E., K. J. Teunissen, H. M. H. Spronk, K. Hamulyák, H. Ten Cate, M. J. Shearer, C. Vermeer, und L. J. Schurgers. „Effect of Low-Dose Supplements of Menaquinone-7 (Vitamin K2 ) on the Stability of Oral Anticoagulant Treatment: Dose-Response Relationship in Healthy Volunteers“. Journal of Thrombosis and Haemostasis: JTH 11, Nr. 6 (Juni 2013): 1085–92. https://doi.org/10.1111/jth.12203.
  35. Gajic-Veljanoski, Olga, Chai W. Phua, Prakesh S. Shah, und Angela M. Cheung. „Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis“. Journal of General Internal Medicine 31, Nr. 8 (August 2016): 947–57. https://doi.org/10.1007/s11606-016-3603-8.
  36. Papadimitriou, Dimitrios T. „The Big Vitamin D Mistake“. Journal of Preventive Medicine and Public Health 50, Nr. 4 (10. Mai 2017): 278–81. https://doi.org/10.3961/jpmph.16.111.
  37. Riek, Amy E., Jisu Oh, Isra Darwech, Clare E. Moynihan, Robin R. Bruchas, und Carlos Bernal-Mizrachi. „25(OH) Vitamin D Suppresses Macrophage Adhesion and Migration by Downregulation of ER Stress and Scavenger Receptor A1 in Type 2 Diabetes“. The Journal of Steroid Biochemistry and Molecular Biology, Proceedings of the 16th Vitamin D Workshop, 144 (1. Oktober 2014): 172–79. https://doi.org/10.1016/j.jsbmb.2013.10.016.
  38. Holick, Michael F., Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, und Connie M. Weaver. „Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline“. The Journal of Clinical Endocrinology & Metabolism 96, Nr. 7 (1. Juli 2011): 1911–30. https://academic.oup.com/jcem/article/96/7/1911/2833671.
  39. Dragh, Maytham A., Zhiliang Xu, Zainab S. Al-Allak, und Ling Hong. „Vitamin K2 Prevents Lymphoma in Drosophila“. Scientific Reports 7 (6. Dezember 2017). https://doi.org/10.1038/s41598-017-17270-9.
  40. „Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial – Bischoff – 2003 – Journal of Bone and Mineral Research – Wiley Online Library“. Zugegriffen 19. November 2019. https://asbmr.onlinelibrary.wiley.com/doi/full/10.1359/jbmr.2003.18.2.343
  1. Melamed, Michal L., Erin D. Michos, Wendy Post, und Brad Astor. „25-hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population“. Archives of internal medicine 168, Nr. 15 (11. August 2008): 1629–37. https://doi.org/10.1001/archinte.168.15.1629.
  2. Lappe, Joan M., Dianne Travers-Gustafson, K. Michael Davies, Robert R. Recker, und Robert P. Heaney. „Vitamin D and Calcium Supplementation Reduces Cancer Risk: Results of a Randomized Trial“. The American Journal of Clinical Nutrition 85, Nr. 6 (Juni 2007): 1586–91. https://doi.org/10.1093/ajcn/85.6.1586.
  3. Rajakumar, Kumaravel, Javier de las Heras, Tai C. Chen, SoJung Lee, Michael F. Holick, und Silva A. Arslanian. „Vitamin D Status, Adiposity, and Lipids in Black American and Caucasian Children“. The Journal of Clinical Endocrinology and Metabolism 96, Nr. 5 (Mai 2011): 1560–67. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085205/.
  4. „Does Vitamin D Deficiency Cause Hypertension? Current Evidence from Clinical Studies and Potential Mechanisms“. Zugegriffen 19. November 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798112/.
  5. Holmøy, Trygve, und Øivind Torkildsen. „Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?“ Expert Review of Neurotherapeutics 16, Nr. 3 (3. März 2016): 233–35. https://doi.org/10.1586/14737175.2016.1146134.
  6. „Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group.“ Diabetologia 42, Nr. 1 (Januar 1999): 51–54. http://www.ncbi.nlm.nih.gov/pubmed/10027578.
  7. Mora, J. Rodrigo, Makoto Iwata, und Ulrich H. von Andrian. „Vitamin effects on the immune system: vitamins A and D take centre stage“. Nature reviews. Immunology 8, Nr. 9 (September 2008): 685–98. https://doi.org/10.1038/nri2378.
  8. Popko, Janusz, Michał Karpiński, Sylwia Chojnowska, Katarzyna Maresz, Robert Milewski, Vladimir Badmaev, und Leon J. Schurgers. „Decreased Levels of Circulating Carboxylated Osteocalcin in Children with Low Energy Fractures: A Pilot Study“. Nutrients 10, Nr. 6 (Juni 2018): 734. https://doi.org/10.3390/nu10060734.
  9. Licher, Silvan, Renée F. A. G. de Bruijn, Frank J. Wolters, M. Carola Zillikens, M. Arfan Ikram, und M. Kamran Ikram. „Vitamin D and the Risk of Dementia: The Rotterdam Study“. Journal of Alzheimer’s Disease: JAD 60, Nr. 3 (2017): 989–97. https://doi.org/10.3233/JAD-170407.
  10. Oliveira, Cesar de, Vasant Hirani, und Jane P Biddulph. „Associations Between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence From the English Longitudinal Study of Ageing (ELSA)“. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 73, Nr. 10 (September 2018): 1377–82. https://doi.org/10.1093/gerona/glx130.
  11. Wong, Sok Kuan, und Kok-Yong Chin and Soelaiman Ima-Nirwana*. „Vitamin D and Depression: The Evidence from an Indirect Clue to Treatment Strategy“. Current Drug Targets, 31. Mai 2018. http://www.eurekaselect.com/155568/article.
  12. Chu, Filmer, Arto Ohinmaa, Scott Klarenbach, Zing-Wae Wong, und Paul Veugelers. „Serum 25-Hydroxyvitamin D Concentrations and Indicators of Mental Health: An Analysis of the Canadian Health Measures Survey“. Nutrients 9, Nr. 10 (13. Oktober 2017). https://doi.org/10.3390/nu9101116.
  13. Amini, Shirin, Sima Jafarirad, und Reza Amani. „Postpartum Depression and Vitamin D: A Systematic Review“. Critical Reviews in Food Science and Nutrition 59, Nr. 9 (2019): 1514–20. https://doi.org/10.1080/10408398.2017.1423276.
  14. Aghajafari, Fariba, Nicole Letourneau, Newsha Mahinpey, Nela Cosic, und Gerald Giesbrecht. „Vitamin D Deficiency and Antenatal and Postpartum Depression: A Systematic Review“. Nutrients 10, Nr. 4 (12. April 2018). https://doi.org/10.3390/nu10040478.
  15. Pettersen, Jacqueline A. „Vitamin D and Executive Functioning: Are Higher Levels Better?“ Journal of Clinical and Experimental Neuropsychology 38, Nr. 4 (2016): 467–77. https://doi.org/10.1080/13803395.2015.1125452.
  16. Pu, Dan, Jing Luo, Yanhua Wang, Bomiao Ju, Xiaohong Lv, Ping Fan, und Lan He. „Prevalence of Depression and Anxiety in Rheumatoid Arthritis Patients and Their Associations with Serum Vitamin D Level“. Clinical Rheumatology 37, Nr. 1 (Januar 2018): 179–84. https://doi.org/10.1007/s10067-017-3874-4.
  17. Vaziri, Farideh, Samira Nasiri, Zohreh Tavana, Mohammad Hossein Dabbaghmanesh, Farkhondeh Sharif, und Peyman Jafari. „A randomized controlled trial of vitamin D supplementation on perinatal depression: in Iranian pregnant mothers“. BMC Pregnancy and Childbirth 16 (20. August 2016). https://doi.org/10.1186/s12884-016-1024-7.
  18. Umar, Meenakshi, Konduru S. Sastry, Fatima Al Ali, Moza Al-Khulaifi, Ena Wang, und Aouatef I. Chouchane. „Vitamin D and the Pathophysiology of Inflammatory Skin Diseases“. Skin Pharmacology and Physiology 31, Nr. 2 (2018): 74–86. https://doi.org/10.1159/000485132.
  19. Finamor, Danilo C, Rita Sinigaglia-Coimbra, Luiz C. M. Neves, Marcia Gutierrez, Jeferson J. Silva, Lucas D. Torres, Fernanda Surano, u. a. „A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis“. Dermato-endocrinology 5, Nr. 1 (1. Januar 2013): 222–34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897595/.
  20. Araki, Takako, Michael F. Holick, Bianca D. Alfonso, Esti Charlap, Carla M. Romero, Dahlia Rizk, und Lisa G. Newman. „Vitamin D Intoxication with Severe Hypercalcemia Due to Manufacturing and Labeling Errors of Two Dietary Supplements Made in the United States“. The Journal of Clinical Endocrinology & Metabolism 96, Nr. 12 (1. Dezember 2011): 3603–8. https://academic.oup.com/jcem/article/96/12/3603/2834898
  21. Jones, Glenville. „Pharmacokinetics of Vitamin D Toxicity“. The American Journal of Clinical Nutrition 88, Nr. 2 (1. August 2008): 582S-586S. https://doi.org/10.1093/ajcn/88.2.582S.
  22. Coimbra, Cicero Galli. „Vitamin D – Heilmittel für MS und Autoimmunerkrankungen? | Dr. Schweikart Verlag“. Zugegriffen 20. November 2019. https://mygrace.ch/wp-content/uploads/2023/02/Vitamin-D-Heilmittel-fuer-MS-und-Autoimmunerkrankungen_-_-Dr.-Schweikart-Verlag-1.pdf
  23. Coimbra, Cicero Galli. „Protocolo COIMBRA (Portugiesisch)“. Protocolo COIMBRA. Zugegriffen 20. November 2019. https://vitaminadporumaoutraterapia.wordpress.com/.
  24. Berridge, Michael J. „Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia)“. American Journal of Physiology-Cell Physiology 314, Nr. 2 (25. Oktober 2017): C135–51. https://doi.org/10.1152/ajpcell.00188.2017.
  25. Máčová, L., M. Bičíková, D. Ostatníková, M. Hill, und L. Stárka. „Vitamin D, Neurosteroids and Autism“. Physiological Research 66, Nr. Supplementum 3 (26. September 2017): S333–40. http://www.biomed.cas.cz/physiolres/pdf/66/66_S333.pdf.
  26. Kimball, Samantha M., Melanie R. Ursell, Paul O’Connor, und Reinhold Vieth. „Safety of Vitamin D3 in Adults with Multiple Sclerosis“. The American Journal of Clinical Nutrition 86, Nr. 3 (1. September 2007): 645–51. https://doi.org/10.1093/ajcn/86.3.645.
  27. „Facebook-Gruppe: PROTOCOLO COIMBRA – BRASIL“. Zugegriffen 21. November 2019. https://www.facebook.com/groups/EscleroseMultiplaOTratamento/.
  28. Heaney, Robert P., K. Michael Davies, Tai C. Chen, Michael F. Holick, und M. Janet Barger-Lux. „Human Serum 25-Hydroxycholecalciferol Response to Extended Oral Dosing with Cholecalciferol“. The American Journal of Clinical Nutrition 77, Nr. 1 (1. Januar 2003): 204–10. https://doi.org/10.1093/ajcn/77.1.204.
  29. McDonnell, Sharon L., Carole Baggerly, Christine B. French, Leo L. Baggerly, Cedric F. Garland, Edward D. Gorham, Joan M. Lappe, und Robert P. Heaney. „Serum 25-Hydroxyvitamin D Concentrations ≥40 Ng/Ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study“. PLOS ONE 11, Nr. 4 (6. April 2016): e0152441. https://doi.org/10.1371/journal.pone.0152441.
  30. Jones, K. S., S. Assar, D. Harnpanich, R. Bouillon, D. Lambrechts, A. Prentice, und I. Schoenmakers. „25(OH)D2 Half-Life Is Shorter than 25(OH)D3 Half-Life and Is Influenced by DBP Concentration and Genotype.“ The Journal of Clinical Endocrinology and Metabolism 99, Nr. 9 (September 2014): 3373–81. https://europepmc.org/articles/PMC4207933/.
  31. Tang, Guangwen, Jian Qin, Gregory G. Dolnikowski, und Robert M. Russell. „Short-Term (Intestinal) and Long-Term (Postintestinal) Conversion of Beta-Carotene to Retinol in Adults as Assessed by a Stable-Isotope Reference Method“. The American Journal of Clinical Nutrition 78, Nr. 2 (August 2003): 259–66. https://doi.org/10.1093/ajcn/78.2.259.
  32. Tang, Guangwen. „Techniques for Measuring Vitamin A Activity from β-Carotene“. The American Journal of Clinical Nutrition 96, Nr. 5 (November 2012): 1185S-8S. https://doi.org/10.3945/ajcn.112.034603.
  33. Novotny, Janet A., Dawn J. Harrison, Robert Pawlosky, Vincent P. Flanagan, Earl H. Harrison, und Anne C. Kurilich. „β-Carotene Conversion to Vitamin A Decreases As the Dietary Dose Increases in Humans“. The Journal of Nutrition 140, Nr. 5 (Mai 2010): 915–18. https://doi.org/10.3945/jn.109.116947.
  34. Bulux, J., J. Quan de Serrano, A. Giuliano, R. Perez, C. Y. Lopez, C. Rivera, N. W. Solomons, und L. M. Canfield. „Plasma Response of Children to Short-Term Chronic Beta-Carotene Supplementation“. The American Journal of Clinical Nutrition 59, Nr. 6 (Juni 1994): 1369–75. https://doi.org/10.1093/ajcn/59.6.1369.
  35. Doldo, Elena, Gaetana Costanza, Sara Agostinelli, Chiara Tarquini, Amedeo Ferlosio, Gaetano Arcuri, Daniela Passeri, Maria Giovanna Scioli, und Augusto Orlandi. „Vitamin A, Cancer Treatment and Prevention: The New Role of Cellular Retinol Binding Proteins“. BioMed Research International 2015 (2015). https://doi.org/10.1155/2015/624627.
  36. Zofková, I., und R. L. Kancheva. „The Relationship between Magnesium and Calciotropic Hormones“. Magnesium Research 8, Nr. 1 (März 1995): 77–84. https://www.ncbi.nlm.nih.gov/pubmed/7669510.
  37. Uwitonze, Anne Marie, und Mohammed S. Razzaque. „Role of Magnesium in Vitamin D Activation and Function“. The Journal of the American Osteopathic Association 118, Nr. 3 (1. März 2018): 181–89. https://doi.org/10.7556/jaoa.2018.037.
  38. Deng, Xinqing, Yiqing Song, JoAnn E Manson, Lisa B Signorello, Shumin M Zhang, Martha J Shrubsole, Reid M Ness, Douglas L Seidner, und Qi Dai. „Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III“. BMC Medicine 11 (27. August 2013): 187. https://doi.org/10.1186/1741-7015-11-187.
  39. Sales, Cristiane Hermes, Lucia Fátima Campos Pedrosa, Josivan Gomes Lima, Telma Maria Araújo Moura Lemos, und Célia Colli. „Influence of Magnesium Status and Magnesium Intake on the Blood Glucose Control in Patients with Type 2 Diabetes“. Clinical Nutrition (Edinburgh, Scotland) 30, Nr. 3 (Juni 2011): 359–64. https://doi.org/10.1016/j.clnu.2010.12.011.
  40. Pizzorno, Lara. „Nothing Boring About Boron“. Integrative Medicine: A Clinician’s Journal 14, Nr. 4 (August 2015): 35–48. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712861/.
  1. Caspi, Ron, Tomer Altman, Kate Dreher, Carol A. Fulcher, Pallavi Subhraveti, Ingrid M. Keseler, Anamika Kothari, u. a. „The MetaCyc Database of Metabolic Pathways and Enzymes and the BioCyc Collection of Pathway/Genome Databases“. Nucleic Acids Research 40, Nr. D1 (1. Januar 2012): D742–53. https://doi.org/10.1093/nar/gkr1014.
  2. Kay, Alan R., und Katalin Tóth. „Is Zinc a Neuromodulator?“ Science signaling 1, Nr. 19 (13. Mai 2008): re3. https://doi.org/10.1126/stke.119re3.
  3. Maret, Wolfgang. „Zinc Biochemistry: From a Single Zinc Enzyme to a Key Element of Life“. Advances in Nutrition 4, Nr. 1 (4. Januar 2013): 82–91. https://doi.org/10.3945/an.112.003038.
  4. Mocchegiani, Eugenio, Javier Romeo, Marco Malavolta, Laura Costarelli, Robertina Giacconi, Ligia-Esperanza Diaz, und Ascension Marcos. „Zinc: dietary intake and impact of supplementation on immune function in elderly“. Age 35, Nr. 3 (Juni 2013): 839–60. https://doi.org/10.1007/s11357-011-9377-3.
  5. Sanna, Alessandro, Davide Firinu, Patrizia Zavattari, und Paolo Valera. „Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis“. Nutrients 10, Nr. 1 (11. Januar 2018). https://doi.org/10.3390/nu10010068.
  6. Udechukwu, M. Chinonye, Stephanie A. Collins, und Chibuike C. Udenigwe. „Prospects of Enhancing Dietary Zinc Bioavailability with Food-Derived Zinc-Chelating Peptides“. Food & Function 7, Nr. 10 (12. Oktober 2016): 4137–44. https://doi.org/10.1039/C6FO00706F.
  7. Wilson, Rebecca L., Jessica A. Grieger, Tina Bianco-Miotto, und Claire T. Roberts. „Association between Maternal Zinc Status, Dietary Zinc Intake and Pregnancy Complications: A Systematic Review“. Nutrients 8, Nr. 10 (15. Oktober 2016). https://doi.org/10.3390/nu8100641.
  8. Gorton, H. Clay, und Kelly Jarvis. „The Effectiveness of Vitamin C in Preventing and Relieving the Symptoms of Virus-Induced Respiratory Infections“. Journal of Manipulative & Physiological Therapeutics 22, Nr. 8 (1. Oktober 1999): 530–33. https://doi.org/10.1016/S0161-4754(99)70005-9.
  9. Iqbal, Khalid, Alam Khan, und Muhammad Muzaffar Ali Khan Khattak. „Biological Significance of Ascorbic Acid (Vitamin C) in Human Health – a Review“. Pakistan Journal of Nutrition 3 (2004): 5–13. https://doi.org/10.3923/pjn.2004.5.13.
  10. Sandesc, Mihai, Alexandru Florin Rogobete, Ovidiu Horea Bedreag, Anca Dinu, Marius Papurica, Carmen Alina Cradigati, Mirela Sarandan, u. a. „Analysis of oxidative stress-related markers in critically ill polytrauma patients: An observational prospective single-center study“. Bosnian Journal of Basic Medical Sciences 18, Nr. 2 (Mai 2018): 191–97. https://doi.org/10.17305/bjbms.2018.2306.
  11. Fowler, Alpha A, Aamer A Syed, Shelley Knowlson, Robin Sculthorpe, Don Farthing, Christine DeWilde, Christine A Farthing, u. a. „Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis“. Journal of Translational Medicine 12 (31. Januar 2014): 32. https://doi.org/10.1186/1479-5876-12-32.
  12. Hibbeln, Joseph. R., und Rachel V. Gow. „Omega-3 Fatty Acid and Nutrient Deficits in Adverse Neurodevelopment and Childhood Behaviors“. Child and adolescent psychiatric clinics of North America 23, Nr. 3 (Juli 2014): 555–90. https://doi.org/10.1016/j.chc.2014.02.002.
  13. Mikirova, Nina, Joseph Casciari, Neil Riordan, und Ronald Hunninghake. „Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients“. Journal of Translational Medicine 11 (15. August 2013): 191. https://doi.org/10.1186/1479-5876-11-191.
  14. „Omega-3 Fatty Acids and Cardiovascular Disease“. European Review, 13. Februar 2015. https://www.europeanreview.org/article/8446.
  15. Brenna, J. Thomas, und Susan E. Carlson. „Docosahexaenoic Acid and Human Brain Development: Evidence That a Dietary Supply Is Needed for Optimal Development“. Journal of Human Evolution, The Role of Freshwater and Marine Resources in the Evolution of the Human Diet, Brain and Behavior, 77 (1. Dezember 2014): 99–106. https://doi.org/10.1016/j.jhevol.2014.02.017.
  16. Endo, Jin, und Makoto Arita. „Cardioprotective Mechanism of Omega-3 Polyunsaturated Fatty Acids“. Journal of Cardiology 67, Nr. 1 (Januar 2016): 22–27. https://doi.org/10.1016/j.jjcc.2015.08.002.
  17. Fine, A. M. „Oligomeric Proanthocyanidin Complexes: History, Structure, and Phytopharmaceutical Applications“. Alternative Medicine Review: A Journal of Clinical Therapeutic 5, Nr. 2 (April 2000): 144–51. https://altmedrev.com/wp-content/uploads/2019/02/v5-2-144.pdf.
  18. Nandakumar, Vijayalakshmi, Tripti Singh, und Santosh K. Katiyar. „Multi-Targeted Prevention and Therapy of Cancer by Proanthocyanidins“. Cancer Letters 269, Nr. 2 (8. Oktober 2008): 378. https://doi.org/10.1016/j.canlet.2008.03.049.
  19. Weseler, Antje R., und Aalt Bast. „Masquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits“. Nutrition Journal 16 (19. Januar 2017). https://doi.org/10.1186/s12937-016-0218-1.
  20. Rodríguez-Pérez, Celia, Belén García-Villanova, Eduardo Guerra-Hernández, und Vito Verardo. „Grape Seeds Proanthocyanidins: An Overview of In Vivo Bioactivity in Animal Models“. Nutrients 11, Nr. 10 (12. Oktober 2019). https://doi.org/10.3390/nu11102435.
  21. Li, Yeshan, Qijun Yu, Wenxue Zhao, Jiaxiang Zhang, Wentao Liu, Mao Huang, und Xiaoning Zeng. „Oligomeric Proanthocyanidins Attenuate Airway Inflammation in Asthma by Inhibiting Dendritic Cells Maturation“. Molecular Immunology 91 (2017): 209–17. https://doi.org/10.1016/j.molimm.2017.09.012.
  22. Scripsema, Nicole K., Dan-Ning Hu, und Richard B. Rosen. „Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease“. Journal of Ophthalmology 2015 (2015). https://doi.org/10.1155/2015/865179.
  23. Jia, Yu-Ping, Lei Sun, He-Shui Yu, Li-Peng Liang, Wei Li, Hui Ding, Xin-Bo Song, und Li-Juan Zhang. „The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases“. Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry 22, Nr. 4 (20. April 2017). https://doi.org/10.3390/molecules22040610.
  24. Kijlstra, Aize, Yuan Tian, Elton R. Kelly, und Tos T. J. M. Berendschot. „Lutein: More than Just a Filter for Blue Light“. Progress in Retinal and Eye Research 31, Nr. 4 (1. Juli 2012): 303–15. https://doi.org/10.1016/j.preteyeres.2012.03.002.
  25. Nowak, Jerzy Z. „AMD–the Retinal Disease with an Unprecised Etiopathogenesis: In Search of Effective Therapeutics“. Acta Poloniae Pharmaceutica 71, Nr. 6 (Dezember 2014): 900–916. https://pubmed.ncbi.nlm.nih.gov/25745762/.
  26. Chew, Emily Y., Traci E. Clemons, John Paul SanGiovanni, Ronald P Danis, Frederick L. Ferris, Michael J. Elman, Andrew Antoszyk, u. a. „Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression AREDS2 Report No.3“. JAMA ophthalmology 132, Nr. 2 (Februar 2014): 142–49. https://doi.org/10.1001/jamaophthalmol.2013.7376.
  27. Garcia Layana, Alfredo, Angelo Maria Minnella, Gerhard Garhöfer, Tariq Aslam, Frank G. Holz, Anita Leys, Rufino Silva, Cécile Delcourt, Eric Souied, und Johanna M. Seddon. „Vitamin D and Age-Related Macular Degeneration“. Nutrients 9, Nr. 10 (13. Oktober 2017). https://doi.org/10.3390/nu9101120.
  28. Perrone, Serafina, Monica Tei, Mariangela Longini, und Giuseppe Buonocore. „The Multiple Facets of Lutein: A Call for Further Investigation in the Perinatal Period“. Oxidative Medicine and Cellular Longevity 2016 (2016). https://doi.org/10.1155/2016/5381540.
  29. Bovier, Emily R., Lisa M. Renzi, und Billy R. Hammond. „A Double-Blind, Placebo-Controlled Study on the Effects of Lutein and Zeaxanthin on Neural Processing Speed and Efficiency“. PLoS ONE 9, Nr. 9 (24. September 2014). https://doi.org/10.1371/journal.pone.0108178.
  30. Grether‐Beck, S., A. Marini, T. Jaenicke, W. Stahl, und J. Krutmann. „Molecular Evidence That Oral Supplementation with Lycopene or Lutein Protects Human Skin against Ultraviolet Radiation: Results from a Double-Blinded, Placebo-Controlled, Crossover Study“. British Journal of Dermatology 176, Nr. 5 (2017): 1231–40. https://doi.org/10.1111/bjd.15080.
  31. Souyoul, Skylar A., Katharine P. Saussy, und Mary P. Lupo. „Nutraceuticals: A Review“. Dermatology and Therapy 8, Nr. 1 (6. Februar 2018): 5–16. https://doi.org/10.1007/s13555-018-0221-x.
  32. Cheng, Ho M., Georgios Koutsidis, John K. Lodge, Ammar W. Ashor, Mario Siervo, und Jose Lara. „Lycopene and Tomato and Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Epidemiological Evidence“. Critical Reviews in Food Science and Nutrition 59, Nr. 1 (2019): 141–58. https://doi.org/10.1080/10408398.2017.1362630.
  33. Jopp, Andreas. Risikofaktor Vitaminmangel: Stoffwechsel und Immunsystem in Topform; Mehr Leistungskraft und eine stabilere Psyche; Schutz gegen Krebs, Herz-Kreislauf-Erkrankungen und Altersdemenz. 5. Stuttgart: TRIAS, 2017. https://www.amazon.de/Risikofaktor-Vitaminmangel-Stoffwechsel-Leistungskraft-Herz-Kreislauf-Erkrankungen/dp/3432101198/.
  34. Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, und W. C. Willett. „Vitamin E Consumption and the Risk of Coronary Heart Disease in Men“. The New England Journal of Medicine 328, Nr. 20 (20. Mai 1993): 1450–56. https://doi.org/10.1056/NEJM199305203282004.
  35. Stampfer, Meir J., Charles H. Hennekens, JoAnn E. Manson, Graham A. Colditz, Bernard Rosner, und Walter C. Willett. „Vitamin E Consumption and the Risk of Coronary Disease in Women“. New England Journal of Medicine 328, Nr. 20 (20. Mai 1993): 1444–49. https://doi.org/10.1056/NEJM199305203282003.
  36. „Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines“. springermedizin.de. Zugegriffen 28. November 2019. https://www.springermedizin.de/vitamin-k2-induces-non-apoptotic-cell-death-along-with-autophago/17284274.
  37. Xv, Fan, Jiepeng Chen, Lili Duan, und Shuzhuang Li. „Research progress on the anticancer effects of vitamin K2 (Review)“. Oncology Letters 15, Nr. 6 (1. Juni 2018): 8926–34. https://doi.org/10.3892/ol.2018.8502.
  38. „📌 Medizinnobelpreis 1943: Henrik Carl Peter Dam — Edward Adelbert Doisy“. Academic dictionaries and encyclopedias. Zugegriffen 30. November 2019. https://mygrace.ch/wp-content/uploads/2023/04/Medizinnobelpreis_1943_Henrik_Carl_Peter_Dam_—_Edward_Adelbert_Doisy.html.
  39. Statistik, Bundesamt für. „Sterblichkeit und deren Hauptursachen in der Schweiz, 2015 – Todesursachenstatistik | Publikation“. Bundesamt für Statistik, 14. November 2017. 259. https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/gesundheitszustand/sterblichkeit-todesursachen/spezifische.assetdetail.3742829.html.
  40. Hartley, Louise, Christine Clar, Obadah Ghannam, Nadine Flowers, Saverio Stranges, und Karen Rees. „- Vitamin K for the Primary Prevention of Cardiovascular Disease“. Cochrane Database of Systematic Reviews, Nr. 9 (2015). https://doi.org/10.1002/14651858.CD011148.pub2.
  1. Kappa Bioscience. „Market Study: K2 Stability 2017“. Zugegriffen 5. Dezember 2019. https://www.kappabio.com/market-study-k2-stability-2017/.
  2. Marles, Robin J., Amy L. Roe, und Hellen A. Oketch-Rabah. „US Pharmacopeial Convention Safety Evaluation of Menaquinone-7, a Form of Vitamin K“. Nutrition Reviews 75, Nr. 7 (1. Juli 2017): 553–78. https://doi.org/10.1093/nutrit/nux022.
  3. Wei, Fang Fei, Sander Trenson, Pierre Monney, Wen Yi Yang, Menno Pruijm, Zhen Yu Zhang, Yassine Bouatou, u. a. „Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction“. Herausgegeben von Vincenzo Lionetti. PLoS ONE 13, Nr. 3 (12. März 2018): e0193967. https://doi.org/10.1371/journal.pone.0193967.
  4. Kasper, Dagmar, Mhammed Bougoussa, und Cees Vermeer. „Assessment of Vitamin K Status by Fully Automated IDS-ISYS InaKtif MGP (Poster)“, o. J., 1. http://www.bone-abstracts.org/ba/0003/eposters/ba0003PP395_eposter.pdf.
  5. Farzamikia, Negin, Ebrahim Sakhinia, und Abbas Afrasiabirad. „Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms“. Laboratory Medicine 49, Nr. 1 (1. Januar 2018): 25–34. https://doi.org/10.1093/labmed/lmx072.

266 N. Hemilä, Harri. „Vitamin C and Infections“. Nutrients 9, Nr. 4 (29. März 2017). https://doi.org/10.3390/nu9040339.

  1. Frerker, Yvonne. „Calciumaufnahme aus Milch – ist dies überhaupt möglich?“ Application/pdf,Online-Datei, 2002. https://doi.org/10.3929/ETHZ-A-004485784.
  2. Hathcock, John N., Andrew Shao, Reinhold Vieth, und Robert Heaney. „Risk Assessment for Vitamin D (>600nmol/l)“. The American Journal of Clinical Nutrition 85, Nr. 1 (1. Januar 2007): 6–18. https://doi.org/10.1093/ajcn/85.1.6.
  3. Holick, Michael F. „Sunlight and Vitamin D for Bone Health and Prevention of Autoimmune Diseases, Cancers, and Cardiovascular Disease“. The American Journal of Clinical Nutrition 80, Nr. 6 (1. Dezember 2004): 1678S-1688S. https://doi.org/10.1093/ajcn/80.6.1678S.
  4. Ogata, Norio, und Takashi Shibata. „Protective Effect of Low-Concentration Chlorine Dioxide Gas against Influenza A Virus Infection“. Journal of General Virology 89, Nr. 1 (1. Januar 2008): 60–67. https://doi.org/10.1099/vir.0.83393-0.
  5. Morino, Hirofumi, Toshiaki Fukuda, Takanori Miura, Cheolsung Lee, Takashi Shibata, und Takeshi Sanekata. „Inactivation of Feline Calicivirus, a Norovirus Surrogate, by Chlorine Dioxide Gas“. Biocontrol Science 14, Nr. 4 (2009): 147–53. https://doi.org/10.4265/bio.14.147.
  6. Sanekata, Takeshi, Toshiaki Fukuda, Takanori Miura, Hirofumi Morino, Cheolsung Lee, Ken Maeda, Kazuko Araki, Toru Otake, Takuya Kawahata, und Takashi Shibata. „Evaluation of the Antiviral Activity of Chlorine Dioxide and Sodium Hypochlorite against Feline Calicivirus, Human Influenza Virus, Measles Virus, Canine Distemper Virus, Human Herpesvirus, Human Adenovirus, Canine Adenovirus and Canine Parvovirus“. Biocontrol Science 15, Nr. 2 (Juni 2010): 45–49. https://doi.org/10.4265/bio.15.45.
  7. H, Morino, Matsubara A, Fukuda T, und Shibata T. „[Inhibition of Hyphal Growth of the Fungus Alternaria Alternata by Chlorine Dioxide Gas at Very Low Concentrations].“ Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan 127, Nr. 4 (1. April 2007): 773–77. https://doi.org/10.1248/yakushi.127.773.
  8. Hodroge, A., B. Matagrin, C. Moreau, I. Fourel, A. Hammed, E. Benoit, und V. Lattard. „VKORC1 Mutations Detected in Patients Resistant to Vitamin K Antagonists Are Not All Associated with a Resistant VKOR Activity“. Journal of Thrombosis and Haemostasis 10, Nr. 12 (2012): 2535–43. https://doi.org/10.1111/jth.12019.